|
US5583024A
(en)
|
1985-12-02 |
1996-12-10 |
The Regents Of The University Of California |
Recombinant expression of Coleoptera luciferase
|
|
IL105456A
(en)
|
1992-04-21 |
1996-12-05 |
American Home Prod |
Vaccines of attenuated respiratory syncytial virus
|
|
AT401526B
(de)
|
1993-02-10 |
1996-09-25 |
Scheirer Winfried |
Reagenzlösung zur stabilisierung der lumineszenz bei der luciferasemessung
|
|
DK0702085T4
(da)
|
1994-07-18 |
2010-04-06 |
Conzelmann Karl Klaus Prof Dr |
Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus
|
|
US7465574B2
(en)
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
|
US6689367B1
(en)
|
1995-09-27 |
2004-02-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US7485440B2
(en)
|
1995-09-27 |
2009-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
|
US6923971B2
(en)
|
1995-09-27 |
2005-08-02 |
The United States Of America As Represented By The Department Of Health & Human Services |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
|
|
US6713066B1
(en)
|
1996-07-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
|
|
US7846455B2
(en)
|
1996-07-15 |
2010-12-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Attenuated chimeric respiratory syncytial virus
|
|
US6264957B1
(en)
|
1995-09-27 |
2001-07-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Product of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
US6214805B1
(en)
|
1996-02-15 |
2001-04-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
RNase L activators and antisense oligonucleotides effective to treat RSV infections
|
|
US6699476B1
(en)
|
1996-07-15 |
2004-03-02 |
Peter L. Collins |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
|
|
EP0912724B1
(en)
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US5976796A
(en)
|
1996-10-04 |
1999-11-02 |
Loma Linda University |
Construction and expression of renilla luciferase and green fluorescent protein fusion genes
|
|
US6074859A
(en)
|
1997-07-08 |
2000-06-13 |
Kikkoman Corporation |
Mutant-type bioluminescent protein, and process for producing the mutant-type bioluminescent protein
|
|
US20040005542A1
(en)
|
2001-06-22 |
2004-01-08 |
Krempl Christine D |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
|
|
US20020018780A1
(en)
*
|
2000-05-25 |
2002-02-14 |
Scott Koenig |
Epitope-based vaccine for respiratory syncytial virus F-protein
|
|
WO2004087062A2
(en)
|
2003-03-28 |
2004-10-14 |
Medimmune Vaccines, Inc. |
Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
|
|
NZ548107A
(en)
|
2003-12-24 |
2009-09-25 |
Nederlanden Staat |
A respiratory syncytial virus with a genomic deficiency complemented in trans
|
|
EP2808384B1
(en)
|
2004-10-08 |
2017-12-06 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Modulation of replicative fitness by using less frequently used synonymous codons
|
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
WO2008133663A2
(en)
|
2006-11-30 |
2008-11-06 |
Government Of The United States Of America, As Represented By The Secretary, |
Codon modified immunogenic compositions and methods of use
|
|
PL2139515T5
(pl)
|
2007-03-30 |
2024-04-08 |
The Research Foundation Of The State University Of New York |
Atenuowane wirusy przydatne w szczepionkach
|
|
US8580270B2
(en)
|
2008-09-30 |
2013-11-12 |
University Of Massachusetts |
Respiratory synctial virus (RSV) sequences for protein expression and vaccines
|
|
BRPI0921424A2
(pt)
|
2008-11-05 |
2016-01-05 |
Merck Sharp & Dohme |
vírus sincicial respiratório atenuado, composição imunogênica, molécula de ácido nucléico, célula recombinante, método para produzir uma resposta imune protetiva em um paciente, e, uso de uma quantidade imunologicamente eficaz de um ou mais dos seguintes: um rsv atenuado, uma população de rsv atenuado e uma composição imunogênica.
|
|
ES2987238T3
(es)
|
2008-12-09 |
2024-11-14 |
Novavax Inc |
Proteínas F del RSV modificadas y métodos de su uso
|
|
EP4183412B1
(en)
|
2009-07-15 |
2024-08-14 |
GlaxoSmithKline Biologicals SA |
Rsv f protein compositions and methods for making same
|
|
WO2011046925A1
(en)
|
2009-10-12 |
2011-04-21 |
Technovax, Inc. |
Respiratory syncytial virus (rsv) virus-like particles (vlps)
|
|
US10227569B2
(en)
|
2011-04-12 |
2019-03-12 |
Emory University |
Respiratory syncytial virus expression vectors
|
|
RS56748B1
(sr)
*
|
2011-05-13 |
2018-03-30 |
Glaxosmithkline Biologicals Sa |
Pre-fuzioni rsv f antigeni
|
|
CA2840982C
(en)
|
2011-07-06 |
2022-06-07 |
Vira BITKO |
Human respiratory syncytial virus vaccine
|
|
US8816081B2
(en)
|
2012-08-06 |
2014-08-26 |
Basf Se |
Boron containing perylene monoimides, a process for their production, their use as building blocks for the production of perylene monoimide derivatives, monoimide derivatives and their use in dye-sensitized solar cells
|
|
CA2900713A1
(en)
|
2013-02-08 |
2014-08-14 |
Steffen Mueller |
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
|
|
US9738689B2
(en)
*
|
2013-03-13 |
2017-08-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Prefusion RSV F proteins and their use
|
|
EP4421177A3
(en)
|
2013-03-13 |
2024-12-18 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Prefusion rsv f proteins and their use
|
|
CN105189756B
(zh)
|
2013-03-14 |
2021-06-11 |
爱默蕾大学 |
具有沉默突变的重组rsv、其相关疫苗和方法
|
|
US9060975B2
(en)
*
|
2013-03-14 |
2015-06-23 |
Mucosis Bv |
Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions
|